A detailed history of Angeles Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Angeles Wealth Management, LLC holds 13,067 shares of ABBV stock, worth $2.22 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
13,067
Previous 12,560 4.04%
Holding current value
$2.22 Million
Previous $2.15 Million 19.78%
% of portfolio
0.22%
Previous 0.2%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $83,066 - $101,060
507 Added 4.04%
13,067 $2.58 Million
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $441,151 - $515,166
2,850 Added 29.35%
12,560 $2.15 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $150,070 - $170,991
939 Added 10.71%
9,710 $1.77 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $344,963 - $388,509
2,507 Added 40.02%
8,771 $1.36 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $25,515 - $29,538
191 Added 3.15%
6,264 $933,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $29,947 - $37,267
-226 Reduced 3.59%
6,073 $818,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $55,096 - $63,451
381 Added 6.44%
6,299 $1 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $113,552 - $136,179
821 Added 16.11%
5,918 $956,000
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $169,238 - $194,105
1,261 Added 32.87%
5,097 $684,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $2,201 - $2,799
-16 Reduced 0.42%
3,836 $588,000
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $508,386 - $630,765
3,852 New
3,852 $624,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Angeles Wealth Management, LLC Portfolio

Follow Angeles Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Angeles Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Angeles Wealth Management, LLC with notifications on news.